CA2586073A1 - Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents - Google Patents
Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents Download PDFInfo
- Publication number
- CA2586073A1 CA2586073A1 CA002586073A CA2586073A CA2586073A1 CA 2586073 A1 CA2586073 A1 CA 2586073A1 CA 002586073 A CA002586073 A CA 002586073A CA 2586073 A CA2586073 A CA 2586073A CA 2586073 A1 CA2586073 A1 CA 2586073A1
- Authority
- CA
- Canada
- Prior art keywords
- arom
- group
- cndot
- alkyl
- cooh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04292629A EP1655288A1 (en) | 2004-11-05 | 2004-11-05 | Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| EP04292629.5 | 2004-11-05 | ||
| PCT/EP2005/012346 WO2006048336A2 (en) | 2004-11-05 | 2005-11-04 | Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2586073A1 true CA2586073A1 (en) | 2006-05-11 |
Family
ID=34931507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002586073A Abandoned CA2586073A1 (en) | 2004-11-05 | 2005-11-04 | Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080096907A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP1655288A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2008519001A (cg-RX-API-DMAC10.html) |
| CN (1) | CN101098860A (cg-RX-API-DMAC10.html) |
| BR (1) | BRPI0517646A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2586073A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2006048336A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI445696B (zh) * | 2010-11-29 | 2014-07-21 | Univ Nat Yang Ming | 標靶人類胸線核苷酸激酶誘導惡性腫瘤中的dna修復毒性 |
| RU2475482C1 (ru) * | 2012-01-13 | 2013-02-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Башкирский государственный университет" | Комплексное соединение 5-гидрокси-6-метилурацила с сукцинатом натрия и способ его получения |
| PL3432887T3 (pl) * | 2016-03-22 | 2021-05-17 | Glaxosmithkline Intellectual Property Development Limited | Środek przeciwgruźliczy |
| US20220041627A1 (en) * | 2018-12-04 | 2022-02-10 | University Of Maryland, Baltimore | Prodrugs of anti-cancer and anti-autoimmune diseases therapeutic agents, and methods of making and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1959705A1 (de) * | 1969-11-28 | 1971-06-03 | Bayer Ag | Verfahren zur Herstellung von Uracilderivaten |
| JPH08325238A (ja) * | 1995-05-30 | 1996-12-10 | Asahi Glass Co Ltd | 5−トリフルオロメチルウラシル誘導体およびその製造方法 |
| ES2157366T3 (es) * | 1995-06-09 | 2001-08-16 | Hoffmann La Roche | Derivados de pirimidindiona, pirimidintriona, triacindiona como antagonistas de receptores alfa-1-adrenergicos. |
| US6608197B2 (en) * | 2000-01-25 | 2003-08-19 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| WO2002061110A2 (en) * | 2001-01-29 | 2002-08-08 | Bio-Rad Laboratories, Inc. | Nucleic acid derivatives |
| US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
-
2004
- 2004-11-05 EP EP04292629A patent/EP1655288A1/en not_active Withdrawn
-
2005
- 2005-11-04 EP EP05819227A patent/EP1814867A2/en not_active Withdrawn
- 2005-11-04 JP JP2007539555A patent/JP2008519001A/ja not_active Withdrawn
- 2005-11-04 WO PCT/EP2005/012346 patent/WO2006048336A2/en not_active Ceased
- 2005-11-04 CA CA002586073A patent/CA2586073A1/en not_active Abandoned
- 2005-11-04 CN CNA2005800460269A patent/CN101098860A/zh active Pending
- 2005-11-04 BR BRPI0517646-8A patent/BRPI0517646A/pt not_active IP Right Cessation
- 2005-11-04 US US11/718,764 patent/US20080096907A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0517646A (pt) | 2008-10-14 |
| WO2006048336A3 (en) | 2006-10-12 |
| JP2008519001A (ja) | 2008-06-05 |
| EP1814867A2 (en) | 2007-08-08 |
| EP1655288A1 (en) | 2006-05-10 |
| WO2006048336B1 (en) | 2006-11-09 |
| WO2006048336A2 (en) | 2006-05-11 |
| CN101098860A (zh) | 2008-01-02 |
| US20080096907A1 (en) | 2008-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dolle et al. | A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors | |
| Ashton et al. | Synthesis and antiherpetic activity of (.+-.)-9-[[(Z)-2-(hydroxymethyl) cyclopropyl] methyl] guanine and related compounds | |
| US5723609A (en) | Bis (hydroxymethyl) cyclobutyl purines | |
| JP5297414B2 (ja) | キサンチンオキシダーゼ阻害剤 | |
| EP2909189B1 (en) | Heteroaryl linked quinolinyl modulators of ror-gamma-t | |
| PL143010B1 (en) | Process for preparing novel derivatives of 1,2,3,5-tetrahydroimidazo/2,1-b/quinazoline | |
| US4400387A (en) | Indolizine derivatives and uses in therapeutics | |
| US20060167253A1 (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile | |
| Tian et al. | Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3, 2-d] pyrimidine analogues as antifolate antitumor agents | |
| US7098220B2 (en) | Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same | |
| CA2366624C (en) | 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents | |
| Brown et al. | Inhibitors of Bacillus subtilis DNA polymerase III. 6-(Arylalkylamino) uracils and 6-anilinouracils | |
| CN109369623A (zh) | 一种取代1,2,3三氮唑类二芳基嘧啶衍生物及其制备方法与应用 | |
| CN112771048B (zh) | 流感病毒复制抑制剂及其中间体和用途 | |
| US20080096907A1 (en) | Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents | |
| CN110078735B (zh) | 具有抗肿瘤活性的吡咯并嘧啶化合物及其用途 | |
| JPH04230669A (ja) | 置換ピリミジン誘導体 | |
| JP2011111433A (ja) | ウレイド構造を有するウラシル化合物又はその塩 | |
| Kaiser et al. | A novel type of acyclic nucleoside phosphonates derived from 2-(phosphonomethoxy) propanoic acid | |
| JPH05117273A (ja) | 医薬化合物 | |
| JPH0643421B2 (ja) | ピリミジン誘導体 | |
| HK1091820A (en) | Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents | |
| EP0303348B1 (en) | 2-amino-5-hydroxy-4-pyrimidones | |
| DE69427394T2 (de) | Kondensierte heterocyclische glutaminsäurederivate als antiproliferative mittel | |
| JPH11510797A (ja) | 4−アリール−チオ−ピリジン−2(1h)−オン、それらを含有する医薬及びそのhivに関連する疾病の治療における使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |